IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma
出版年份 2021 全文链接
标题
IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma
作者
关键词
-
出版物
ONCOGENE
Volume 40, Issue 35, Pages 5393-5402
出版商
Springer Science and Business Media LLC
发表日期
2021-07-17
DOI
10.1038/s41388-021-01939-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
- (2019) Harmen van Andel et al. LEUKEMIA
- Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
- (2019) Jasmin Paris et al. Cell Stem Cell
- Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
- (2019) Hailing Shi et al. MOLECULAR CELL
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential
- (2018) Ingrid Spaan et al. Journal of Hematology & Oncology
- N 6 -Methyladenosine Guides mRNA Alternative Translation during Integrated Stress Response
- (2018) Jun Zhou et al. MOLECULAR CELL
- Novel biomarkers in multiple myeloma
- (2018) Adam Levin et al. Translational Research
- Amazing Diversity in Biochemical Roles of Fe(II)/2-Oxoglutarate Oxygenases
- (2018) Caitlyn Q Herr et al. TRENDS IN BIOCHEMICAL SCIENCES
- Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
- (2018) Zhenrui Li et al. CELL RESEARCH
- IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
- (2018) Elisa Bergaggio et al. BLOOD
- The Biology of m6A RNA Methylation in Normal and Malignant Hematopoiesis
- (2018) Ly P. Vu et al. Cancer Discovery
- The RNA m 6 A Reader YTHDF2 Is Essential for the Post-transcriptional Regulation of the Maternal Transcriptome and Oocyte Competence
- (2017) Ivayla Ivanova et al. MOLECULAR CELL
- N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3′-end processing
- (2017) Marek Bartosovic et al. NUCLEIC ACIDS RESEARCH
- Epigenetics in multiple myeloma: From mechanisms to therapy
- (2017) Mohammad Alzrigat et al. SEMINARS IN CANCER BIOLOGY
- The emerging role and targetability of the TCA cycle in cancer metabolism
- (2017) Nicole M. Anderson et al. Protein & Cell
- Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
- (2016) Niels W. C. J. van de Donk et al. IMMUNOLOGICAL REVIEWS
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Genomic heterogeneity in multiple myeloma
- (2015) Raphaël Szalat et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
- (2014) Xu Zhao et al. CELL RESEARCH
- Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance
- (2014) Lev M. Kats et al. Cell Stem Cell
- Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies
- (2014) L. Lopez-Corral et al. HAEMATOLOGICA
- The role of epigenetics in the biology of multiple myeloma
- (2014) K Dimopoulos et al. Blood Cancer Journal
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
- (2012) H. Yang et al. CLINICAL CANCER RESEARCH
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
- (2011) Rasheduzzaman Chowdhury et al. EMBO REPORTS
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
- (2011) M Fernanda Amary et al. JOURNAL OF PATHOLOGY
- Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome
- (2011) Twinkal C Pansuriya et al. NATURE GENETICS
- KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
- (2011) Chen Xie et al. NUCLEIC ACIDS RESEARCH
- A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect
- (2009) Luca Agnelli et al. GENES CHROMOSOMES & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started